# Empagliflozin protects the kidney by reducing toxic ALB (albumin) exposure and preventing autophagic stagnation in proximal tubules

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/empagliflozin-protects-the-kidney-by-reducing-toxic-alb-albumin-exposure-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sho Matsui,Takeshi Yamamoto,Yoshitsugu Takabatake,Atsushi Takahashi,Tomoko Namba‐Hamano,Jun Matsuda,Satoshi Minami,Shinsuke Sakai,Hiroaki Yonishi,Jun Nakamura,Shihomi Maeda,Ayumi Matsumoto,Isao Matsui,Motoko Yanagita,Yoshitaka Isaka |
| Citations | 22 |
| DOI | 10.1080/15548627.2024.2410621 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/15548627.2024.2410621?needAccess=true |
| OpenAlex ID | https://openalex.org/W4403301515 |
| PMID | 39385699 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Yoshitaka Isaka](https://scholariq.org/researchers/yoshitaka-isaka/)

## Paper primary topic

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Paper topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.